Tag: Pharma acquisition news

AstraZeneca to acquire Gracell Biotechnologies for $1.2bn to expand cell therapy capabilities

businessnewstoday- January 2, 2024

AstraZeneca has announced a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL) for an upfront cash payment of $1.0 billion, representing a 62% ... Read More

Eli Lilly and Company completes $1.4bn acquisition of POINT Biopharma

businessnewstoday- December 31, 2023

Eli Lilly and Company (NYSE: LLY) has announced the successful completion of its $1.4 billion acquisition of POINT Biopharma Global Inc. (NASDAQ: PNT), a notable ... Read More

Windjammer Capital acquires monoclonal antibodies producer Bio X Cell

businessnewstoday- December 13, 2023

Windjammer Capital Investors ("Windjammer"), a notable private equity investment firm, has announced its acquisition of Bio X Cell, LLC ("BXC"), marking a significant move in ... Read More

AstraZeneca to acquire Icosavax in $1.1bn deal to boost vaccine development

businessnewstoday- December 13, 2023

In a definitive move, AstraZeneca has entered into an agreement to acquire Icosavax, Inc., a U.S.-based biopharmaceutical company specializing in innovative vaccines. This acquisition, valued ... Read More

Sun Pharmaceutical proposes revised offer for Taro Pharmaceutical acquisition

businessnewstoday- December 12, 2023

In a notable development within the pharmaceutical industry, Sun Pharmaceutical Industries Limited has expressed a non-binding interest in acquiring shares of Taro Pharmaceutical Industries Ltd. ... Read More

AbbVie to acquire Cerevel Therapeutics for $8.7bn to expand neuroscience research

businessnewstoday- December 7, 2023

AbbVie Inc. (NYSE: ABBV) and Cerevel Therapeutics (NASDAQ: CERE) have announced a definitive agreement in which AbbVie will acquire Cerevel Therapeutics. The transaction, valued at ... Read More

Roche to acquire Carmot Therapeutics to expand obesity treatment portfolio

businessnewstoday- December 6, 2023

Roche announced its definitive agreement to acquire Carmot Therapeutics, Inc., based in Berkeley, California, for an upfront purchase price of USD 2.7 billion, with additional ... Read More

AbbVie to acquire ImmunoGen for $10.1bn to expand oncology portfolio

businessnewstoday- December 1, 2023

AbbVie Inc. and ImmunoGen Inc. have entered into a definitive agreement, marking a significant move in the pharmaceutical industry. AbbVie will acquire ImmunoGen, including its ... Read More

Boehringer Ingelheim expands oncology portfolio with T3 Pharma acquisition

businessnewstoday- November 22, 2023

Boehringer Ingelheim announced its acquisition of T3 Pharmaceuticals AG (“T3 Pharma”), a Swiss biotech company specializing in immuno-oncology, for up to 450 million CHF. T3 ... Read More

Merck to acquire Caraway Therapeutics in $610m deal for neurodegenerative disease treatments

businessnewstoday- November 22, 2023

Merck and Caraway Therapeutics, Inc. have announced a definitive agreement in which Merck, through a subsidiary, will acquire Caraway Therapeutics. The total potential consideration for ... Read More